Logo image of CASK

HERITAGE DISTILLING HOLDING (CASK) Stock Fundamental Analysis

NASDAQ:CASK - Nasdaq - US42727R1041 - Common Stock - Currency: USD

0.5302  +0.03 (+5.01%)

Premarket: 0.55 +0.02 (+3.73%)

Fundamental Rating

0

CASK gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. CASK has a bad profitability rating. Also its financial health evaluation is rather negative. CASK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CASK has reported negative net income.
CASK Yearly Net Income VS EBIT VS OCF VS FCFCASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of 0.87%, CASK is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.87%
ROE N/A
ROIC N/A
ROA(3y)-70.99%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CASK Yearly ROA, ROE, ROICCASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100

1.3 Margins

Looking at the Profit Margin, with a value of 3.48%, CASK is doing worse than 62.50% of the companies in the same industry.
CASK has a worse Gross Margin (32.83%) than 84.38% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 3.48%
GM 32.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CASK Yearly Profit, Operating, Gross MarginsCASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

CASK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CASK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, CASK has a worse debt to assets ratio.
CASK Yearly Shares OutstandingCASK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
CASK Yearly Total Debt VS Total AssetsCASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

CASK has an Altman-Z score of -5.33. This is a bad value and indicates that CASK is not financially healthy and even has some risk of bankruptcy.
CASK has a worse Altman-Z score (-5.33) than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.33
ROIC/WACCN/A
WACC5.53%
CASK Yearly LT Debt VS Equity VS FCFCASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 10M -10M -20M -30M -40M

2.3 Liquidity

A Current Ratio of 0.13 indicates that CASK may have some problems paying its short term obligations.
CASK has a Current ratio of 0.13. This is amonst the worse of the industry: CASK underperforms 93.75% of its industry peers.
A Quick Ratio of 0.05 indicates that CASK may have some problems paying its short term obligations.
CASK's Quick ratio of 0.05 is on the low side compared to the rest of the industry. CASK is outperformed by 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.05
CASK Yearly Current Assets VS Current LiabilitesCASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

CASK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -199.95%.
The Revenue has decreased by -4.07% in the past year.
EPS 1Y (TTM)-199.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-4.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CASK Yearly Revenue VS EstimatesCASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CASK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CASK Price Earnings VS Forward Price EarningsCASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CASK Per share dataCASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CASK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HERITAGE DISTILLING HOLDING

NASDAQ:CASK (5/22/2025, 8:00:02 PM)

Premarket: 0.55 +0.02 (+3.73%)

0.5302

+0.03 (+5.01%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.25%
Inst Owner Change-42.99%
Ins Owners15.08%
Ins Owner Change57.31%
Market Cap3.67M
AnalystsN/A
Price TargetN/A
Short Float %4.98%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.12
BVpS-4.91
TBVpS-5.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.48%
GM 32.83%
FCFM N/A
ROA(3y)-70.99%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.05
Altman-Z -5.33
F-ScoreN/A
WACC5.53%
ROIC/WACCN/A
Cap/Depr(3y)46.44%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-199.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.79%
OCF growth 3YN/A
OCF growth 5YN/A